Vectors Research Management’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $530K | Hold |
5,122
| – | – | 0.14% | 103 |
|
|
2026
Q1 | $368K | Buy |
5,122
+68
| +1% | +$5.24K | 0.11% | 112 |
|
|
2025
Q4 | $401K | Sell |
5,054
-19
| -0.4% | -$1.5K | 0.12% | 102 |
|
|
2025
Q3 | $382K | Hold |
5,073
| – | – | 0.12% | 106 |
|
|
2025
Q2 | $350K | Hold |
5,073
| – | – | 0.12% | 97 |
|
|
2025
Q1 | $344K | Hold |
5,073
| – | – | 0.12% | 95 |
|
|
2024
Q4 | $228K | Hold |
5,073
| – | – | 0.08% | 112 |
|
|
2024
Q3 | $310K | Hold |
5,073
| – | – | 0.09% | 104 |
|
|
2024
Q2 | $300K | Sell |
5,073
-27,670
| -85% | -$1.73M | 0.09% | 112 |
|
|
2024
Q1 | $2.61M | Buy |
32,743
+9,025
| +38% | +$689K | 0.74% | 37 |
|
|
2023
Q4 | $2.73M | Sell |
23,718
-12,371
| -34% | -$880K | 0.77% | 33 |
|
|
2023
Q3 | $2.34M | Sell |
36,089
-627
| -2% | -$44.4K | 0.76% | 37 |
|
|
2023
Q2 | $2.54M | Sell |
36,716
-2,342
| -6% | -$167K | 0.72% | 34 |
|
|
2023
Q1 | $2.9M | Sell |
39,058
-582
| -1% | -$48.8K | 0.75% | 34 |
|
|
2022
Q4 | $3.69M | Sell |
39,640
-896
| -2% | -$86.5K | 0.96% | 23 |
|
|
2022
Q3 | $3.87M | Buy |
40,536
+9,406
| +30% | +$931K | 1.09% | 19 |
|
|
2022
Q2 | $2.88M | Sell |
31,130
-655
| -2% | -$63.9K | 0.73% | 36 |
|
|
2022
Q1 | $3.22M | Sell |
31,785
-2,854
| -8% | -$300K | 0.71% | 35 |
|
|
2021
Q4 | $3.57M | Buy |
34,639
+269
| +0.8% | +$24.9K | 0.75% | 36 |
|
|
2021
Q3 | $2.92M | Buy |
34,370
+634
| +2% | +$53.1K | 0.69% | 34 |
|
|
2021
Q2 | $2.81M | Sell |
33,736
-226
| -0.7% | -$18.5K | 0.72% | 33 |
|
|
2021
Q1 | $2.56M | Buy |
33,962
+1,544
| +5% | +$112K | 0.7% | 37 |
|
|
2020
Q4 | $2.21M | Buy |
32,418
+2,494
| +8% | +$162K | 0.68% | 40 |
|
|
2020
Q3 | $1.76M | Buy |
29,924
+15
| +0.1% | +$933 | 0.65% | 42 |
|
|
2020
Q2 | $1.94M | Buy |
29,909
+368
| +1% | +$23.2K | 0.77% | 38 |
|
|
2020
Q1 | $1.75M | Buy |
29,541
+14,711
| +99% | +$982K | 0.83% | 31 |
|
|
2019
Q4 | $1.1M | Buy |
14,830
+5,075
| +52% | +$356K | 0.44% | 51 |
|
|
2019
Q3 | $615K | Buy |
9,755
+226
| +2% | +$13.4K | 0.3% | 64 |
|
|
2019
Q2 | $519K | Sell |
9,529
-183
| -2% | -$9.86K | 0.28% | 67 |
|
|
2019
Q1 | $524K | Buy |
9,712
+5,654
| +139% | +$349K | 0.3% | 65 |
|
|
2018
Q4 | $266K | Sell |
4,058
-5,136
| -56% | -$383K | 0.13% | 99 |
|
|
2018
Q3 | $599K | Buy |
+9,194
| New | +$657K | 0.37% | 61 |
|
Other funds holding CVS
Vectors Research Management's CVS Position: Q2 2026 in Review
Vectors Research Management held its CVS Health (CVS) position steady in Q2 2026 at 5,122 shares worth $530K. The position accounts for 0.14% of the portfolio, ranked #103.
Vectors Research Management first reported a position in CVS in Q3 2018 and has held it in 32 quarters since. The position peaked at $3.87M in Q3 2022. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.
- Vectors Research Management held 5,122 shares of CVS Health worth $530K as of Q2 2026.
- Vectors Research Management left its CVS Health share count unchanged in Q2 2026.
- CVS Health made up 0.14% of Vectors Research Management's portfolio in Q2 2026, its #103 holding.
- Vectors Research Management first reported a position in CVS Health in Q3 2018 and has held it in 32 quarters since.
- Vectors Research Management's CVS Health position peaked at $3.87M in Q3 2022.
- 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.
Based on Vectors Research Management's 13F filing for Q2 2026, filed 29 Jul 2026.